Abiopharma

🔍 Bacos Anthony (Executive)

Company: Stitch Fix, Inc. (SFIX)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Class A Common Stock at $2.48 per share (Direct)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,155,109.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 50,000 shares of Class A Common Stock at $4.1369 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,105,109.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 20,000 shares of Class A Common Stock at $4.1666 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,085,109.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 50,000 shares of Employee Stock Option (Right to Buy) at $2.48 per share (Derivative)
  Date: 2026-06-16 | Code: M | Expires: 2034-04-01 | equity_swap_involved: 0 | shares_owned_after: 672,543.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
• F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $4.085 to $4.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.